Neurology

The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.

Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.

Based on evidence from several clinical trials, an FDA advisory committee has voted unanimously to recommend the approval of a cannabis-based oral solution for the treatment of 2 rare forms of epilepsy. ...

In 2006, the US Food and Drug Administration issued an advisory that warned of the risk for serotonin syndrome with concomitant use of triptans and certain antidepressants. In a recent study, researchers...

The US Food and Drug Administration recently approved the first blood test to aid in assessing mild traumatic brain injury in adults.

The US Food and Drug Administration has recently approved a new smart watch that can monitor seizure activity and alert caregivers.

The FDA has expanded the approval of a drug to include the treatment of adults with lower limb spasticity.

The FDA has approved new options for lower limb spasticity, relapsed multiple myeloma, and diabetic foot ulcers that healthcare professionals should be aware of.

The FDA has approved new options for the treatment of presbyopia and multiple sclerosis, and issued a recall after an outbreak of listeria.